Annual Current Liabilities
$48.61 M
+$5.31 M+12.27%
31 March 2024
Summary:
Immunovant annual total current liabilities is currently $48.61 million, with the most recent change of +$5.31 million (+12.27%) on 31 March 2024. During the last 3 years, it has risen by +$29.84 million (+158.95%). IMVT annual current liabilities is now at all-time high.IMVT Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$66.65 M
+$21.64 M+48.06%
30 September 2024
Summary:
Immunovant quarterly total current liabilities is currently $66.65 million, with the most recent change of +$21.64 million (+48.06%) on 30 September 2024. Over the past year, it has increased by +$26.39 million (+65.56%). IMVT quarterly current liabilities is now at all-time high.IMVT Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMVT Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.3% | +65.6% |
| 3 y3 years | +158.9% | +134.8% |
| 5 y5 years | +10000.0% | +10000.0% |
IMVT Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +158.9% | at high | +213.8% |
| 5 y | 5 years | at high | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Immunovant Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $66.65 M(+48.1%) |
| June 2024 | - | $45.02 M(-7.4%) |
| Mar 2024 | $48.61 M(+12.3%) | $48.61 M(+51.4%) |
| Dec 2023 | - | $32.10 M(-20.3%) |
| Sept 2023 | - | $40.26 M(-21.6%) |
| June 2023 | - | $51.36 M(+18.6%) |
| Mar 2023 | $43.30 M(-2.7%) | $43.30 M(+4.9%) |
| Dec 2022 | - | $41.26 M(+29.8%) |
| Sept 2022 | - | $31.78 M(+49.6%) |
| June 2022 | - | $21.24 M(-52.3%) |
| Mar 2022 | $44.52 M | $44.52 M(+22.5%) |
| Dec 2021 | - | $36.35 M(+28.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $28.38 M(+38.3%) |
| June 2021 | - | $20.52 M(+9.3%) |
| Mar 2021 | $18.77 M(+22.5%) | $18.77 M(+13.9%) |
| Dec 2020 | - | $16.48 M(+28.7%) |
| Sept 2020 | - | $12.81 M(-34.5%) |
| June 2020 | - | $19.54 M(+27.6%) |
| Mar 2020 | $15.32 M(+3926.8%) | $15.32 M(+3.8%) |
| Dec 2019 | - | $14.76 M(+4271.1%) |
| Sept 2019 | - | $337.60 K(+270.6%) |
| June 2019 | - | $91.10 K(-69.7%) |
| Mar 2019 | - | $300.40 K |
| Dec 2018 | $380.40 K | - |
FAQ
- What is Immunovant annual total current liabilities?
- What is the all time high annual current liabilities for Immunovant?
- What is Immunovant annual current liabilities year-on-year change?
- What is Immunovant quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Immunovant?
- What is Immunovant quarterly current liabilities year-on-year change?
What is Immunovant annual total current liabilities?
The current annual current liabilities of IMVT is $48.61 M
What is the all time high annual current liabilities for Immunovant?
Immunovant all-time high annual total current liabilities is $48.61 M
What is Immunovant annual current liabilities year-on-year change?
Over the past year, IMVT annual total current liabilities has changed by +$5.31 M (+12.27%)
What is Immunovant quarterly total current liabilities?
The current quarterly current liabilities of IMVT is $66.65 M
What is the all time high quarterly current liabilities for Immunovant?
Immunovant all-time high quarterly total current liabilities is $66.65 M
What is Immunovant quarterly current liabilities year-on-year change?
Over the past year, IMVT quarterly total current liabilities has changed by +$26.39 M (+65.56%)